SCHEMBL23660865

SCHEMBL23660865

CNCCNNC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6845221 0.88
SCHEMBL10860295 0.84 CARM1 (0.39)
Hydrochloric Acid SCHEMBL14660103 0.84 KDM4E (0.42)
SCHEMBL11615777 0.79
SCHEMBL14716928 0.78 CARM1 (0.47)
SCHEMBL5425 0.78
SCHEMBL20477518 0.76 EPHX1 (0.55)
Iodide SCHEMBL7118709 0.74
Ammonia Solution, Strong SCHEMBL2487756 0.74
Ammonia Solution, Strong SCHEMBL734851 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3888685-A1 DRUG CONTAINING LIVER TARGETING SPECIFIC LIGAND AND THYROID HORMONE RECEPTOR AGONIST Kylonova (Xiamen) Biopharma Co., Ltd. (CN) 2021-10-06 EP disclosed
WO-2021143822-A1 BICYCLIC IMIDE DERIVATIVE, PREPARATION METHOD THEREOF, AND APPLICATION THEREOF IN MEDICINE 江苏恒瑞医药股份有限公司 2021-07-22 WO disclosed